Quick Read Pfizer acquired Metsera for $10B to enter the weight loss drug market. Target fell 27% over the past year despite ...

Investors love dividend stocks, especially blue-chip varieties, because they offer a significant income stream and ...

I’m a contrarian at heart—but sometimes even contrarians have to go along with the mainstream opinion. This (as much as it ...

The market reacts to headlines, not fundamentals. Deep discounts in dividend growth stocks may offer rare high yields and upside—explore these ...

This Dividend King doesn't go on sale very often, but it currently has an above-market yield and a fair valuation.

One of these companies has been paying a consecutive dividend for more than two centuries.

We’ll talk about how we can get in at a bargain—a “double discount,” if you will—and grab that growing 7.2% dividend, too.

If analysts are correct, lower interest rates today will bring an unwelcome spike in inflation in 2026. While it may not be anything like the 7% to 8% inflation rate of 2022 and 2023, the consensus ...

The healthcare giant has had trouble winning over investors in the past year despite an incredibly low valuation.

YOU don’t need to be rich to start making money from investing – all you need a couple of quid. If you don’t have a lot of ...

Despite offering high dividend returns at a low price, missteps and revenue declines may dampen the appeal of Altria stock.